Intellectual property. Biotech feels a chill from changing U.S. patent rules

Kelly Servick. Science. 2014.

. 2014 Jul 4;345(6192):14-5.

doi: 10.1126/science.345.6192.14.

No abstract available

Similar articles

Intellectual property. Supreme Court rules out patents on 'natural' genes.
Marshall E. Marshall E. Science. 2013 Jun 21;340(6139):1387-8. doi: 10.1126/science.340.6139.1387. Science. 2013. PMID: 23788772 No abstract available.
Supreme Court boosts licensees in biotech patent battles.
Waltz E. Waltz E. Nat Biotechnol. 2007 Mar;25(3):264-5. doi: 10.1038/nbt0307-264. Epub 2007 Mar 1. Nat Biotechnol. 2007. PMID: 17344866 No abstract available.
Genes can't be patented, rules Supreme Court.
McCarthy M. McCarthy M. BMJ. 2013 Jun 14;346:f3907. doi: 10.1136/bmj.f3907. BMJ. 2013. PMID: 23771229 No abstract available.
Patentability of Stem Cells in the United States.
Fendrick SE, Zuhn DL Jr. Fendrick SE, et al. Cold Spring Harb Perspect Med. 2015 Aug 20;5(12):a020958. doi: 10.1101/cshperspect.a020958. Cold Spring Harb Perspect Med. 2015. PMID: 26292987 Free PMC article. Review.
The Impact of Myriad on the Future Development and Commercialization of DNA-Based Therapies and Diagnostics.
Wales M, Cartier E. Wales M, et al. Cold Spring Harb Perspect Med. 2015 Sep 3;5(12):a020925. doi: 10.1101/cshperspect.a020925. Cold Spring Harb Perspect Med. 2015. PMID: 26337114 Free PMC article. Review.